Ampio Pharmaceuticals, Inc. Gains 28.32%
Tue, Nov 22, 2022 at 07:25 PM
Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT) shot up at $0.03, representing a gain of 28.3%. The stock got featured on our News Catalysts scanner on Tue, Nov 08, 2022 at 07:22 PM in the 'SPLIT' category. From Tue, Nov 08, 2022, the stock recorded 50.00% Up Days and 63.64% Green Days
The stock spiked on Fri, Sep 02, 2022 at $1.9 with a volume of 3M+.
About Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT)
Ampio Pharmaceuticals Inc is a biopharmaceutical company. The company is engaged in the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options.
Top 10 Gainers:
- Palisade Bio Inc. (PALI:NASDAQ), 81.08%
- Motorsport Games Inc. (MSGM:NASDAQ), 51.11%
- FOXO Technologies Inc. Class A (FOXO:NYSEMKT), 47.57%
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 34.31%
- XL Group Ltd (XL:NYSE), 30.91%
- Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ), 30%
- Digital Brands Group Inc. (DBGI:NASDAQ), 28.53%
- Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT), 28.32%
- Draganfly Inc. (DPRO:NASDAQ), 27.19%
- GH Research PLC (GHRS:NASDAQ), 25.86%